PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,155,328 | +443.3% | 213,914 | +138.3% | 0.01% | +400.0% |
| Q4 2022 | $948,869 | +493.0% | 89,770 | +151.6% | 0.00% | – |
| Q3 2022 | $160,000 | +14.3% | 35,677 | +1.0% | 0.00% | – |
| Q2 2022 | $140,000 | -48.3% | 35,331 | -4.7% | 0.00% | – |
| Q1 2022 | $271,000 | +26.6% | 37,080 | -2.8% | 0.00% | – |
| Q4 2021 | $214,000 | -5.7% | 38,161 | +6.9% | 0.00% | – |
| Q3 2021 | $227,000 | -13.4% | 35,707 | +14.6% | 0.00% | – |
| Q2 2021 | $262,000 | -30.1% | 31,166 | -12.9% | 0.00% | – |
| Q1 2021 | $375,000 | -53.5% | 35,775 | -24.9% | 0.00% | – |
| Q4 2020 | $807,000 | +159.5% | 47,614 | +96.4% | 0.00% | – |
| Q3 2020 | $311,000 | -7.2% | 24,240 | +2.1% | 0.00% | – |
| Q2 2020 | $335,000 | +67.5% | 23,747 | +8.8% | 0.00% | – |
| Q1 2020 | $200,000 | -89.2% | 21,820 | -82.4% | 0.00% | -100.0% |
| Q4 2019 | $1,844,000 | – | 123,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |